1. Home
  2. TVTX vs SAH Comparison

TVTX vs SAH Comparison

Compare TVTX & SAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • SAH
  • Stock Information
  • Founded
  • TVTX 2008
  • SAH 1997
  • Country
  • TVTX United States
  • SAH United States
  • Employees
  • TVTX N/A
  • SAH N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • SAH Other Specialty Stores
  • Sector
  • TVTX Health Care
  • SAH Consumer Discretionary
  • Exchange
  • TVTX Nasdaq
  • SAH Nasdaq
  • Market Cap
  • TVTX 2.5B
  • SAH 2.8B
  • IPO Year
  • TVTX N/A
  • SAH 1997
  • Fundamental
  • Price
  • TVTX $29.05
  • SAH $64.50
  • Analyst Decision
  • TVTX Strong Buy
  • SAH Buy
  • Analyst Count
  • TVTX 15
  • SAH 8
  • Target Price
  • TVTX $34.86
  • SAH $81.88
  • AVG Volume (30 Days)
  • TVTX 1.8M
  • SAH 178.4K
  • Earning Date
  • TVTX 10-30-2025
  • SAH 10-23-2025
  • Dividend Yield
  • TVTX N/A
  • SAH 2.36%
  • EPS Growth
  • TVTX N/A
  • SAH N/A
  • EPS
  • TVTX N/A
  • SAH 3.73
  • Revenue
  • TVTX $333,865,000.00
  • SAH $15,178,100,000.00
  • Revenue This Year
  • TVTX $83.23
  • SAH $4.86
  • Revenue Next Year
  • TVTX $41.49
  • SAH $3.51
  • P/E Ratio
  • TVTX N/A
  • SAH $17.23
  • Revenue Growth
  • TVTX 87.94
  • SAH 9.09
  • 52 Week Low
  • TVTX $12.91
  • SAH $52.00
  • 52 Week High
  • TVTX $28.85
  • SAH $89.62
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 73.62
  • SAH 28.41
  • Support Level
  • TVTX $26.79
  • SAH $70.70
  • Resistance Level
  • TVTX $28.24
  • SAH $77.85
  • Average True Range (ATR)
  • TVTX 1.02
  • SAH 2.62
  • MACD
  • TVTX -0.01
  • SAH -0.92
  • Stochastic Oscillator
  • TVTX 100.00
  • SAH 0.00

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About SAH Sonic Automotive Inc.

Sonic Automotive is one of the largest auto dealership groups in the United States. The company has 108 franchised stores in 18 states, primarily in metropolitan areas in California, Texas, and the Southeast, plus 18 EchoPark used-vehicle stores, 16 collision centers, and 14 powersports locations. The franchise stores derive revenue from new and used vehicles plus parts and collision repair, finance, insurance, and wholesale auctions. Luxury and import dealerships make up about 86% of franchise new-vehicle revenue, while Honda, BMW, Mercedes, and Toyota constitute about 59% of new-vehicle revenue. BMW is the largest brand at about 25%. 2024's revenue was $14.2 billion, with Texas and California comprising 51% of the total. EchoPark's portion was $2.1 billion.

Share on Social Networks: